Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MNTA

Momenta

$14.16

0.13 (0.93%)

, ARGX

Argenx

$132.33

2.6 (2.00%)

06:42
03/18/19
03/18
06:42
03/18/19
06:42
Initiation
Momenta, Argenx initiated at BTIG »

Momenta initiated with a…

MNTA

Momenta

$14.16

0.13 (0.93%)

ARGX

Argenx

$132.33

2.6 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

Over a week ago
ARGX

Argenx

$132.82

-1.54 (-1.15%)

07:11
03/01/19
03/01
07:11
03/01/19
07:11
Recommendations
Argenx analyst commentary at Wedbush »

Argenx removed from Best…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$122.20

-2.84 (-2.27%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Initiation
Argenx initiated at Guggenheim »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ARGX

Argenx

$115.07

2.25 (1.99%)

11:25
02/13/19
02/13
11:25
02/13/19
11:25
Conference/Events
Argenx management to meet with Wolfe Research »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

ARGX

Argenx

$112.82

3.91 (3.59%)

04:55
02/13/19
02/13
04:55
02/13/19
04:55
Conference/Events
Argenx management to meet with Wolfe Research »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

ARGX

Argenx

$110.89

-0.91 (-0.81%)

12:12
02/06/19
02/06
12:12
02/06/19
12:12
Conference/Events
Argenx management to meet with Wolfe Research »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$110.39

-0.92 (-0.83%)

, HALO

Halozyme

$16.89

0.27 (1.62%)

11:35
02/05/19
02/05
11:35
02/05/19
11:35
Recommendations
Argenx, Halozyme, Johnson & Johnson analyst commentary at Piper Jaffray »

Piper says argenx…

ARGX

Argenx

$110.39

-0.92 (-0.83%)

HALO

Halozyme

$16.89

0.27 (1.62%)

JNJ

Johnson & Johnson

$133.10

0.24 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 06

    Mar

HALO

Halozyme

$16.12

-0.05 (-0.31%)

, ARGX

Argenx

$108.49

2.35 (2.21%)

05:33
02/04/19
02/04
05:33
02/04/19
05:33
Hot Stocks
Halozyme, Argenx enter collaboration agreement for Enhanze »

Argenx (ARGX) and…

HALO

Halozyme

$16.12

-0.05 (-0.31%)

ARGX

Argenx

$108.49

2.35 (2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$104.07

0.44 (0.42%)

12:03
01/15/19
01/15
12:03
01/15/19
12:03
Hot Stocks
Argenx granted orphan status for acute myeloid leukemia treatment »

The FDA granted Argenx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$111.87

2.39 (2.18%)

15:15
01/08/19
01/08
15:15
01/08/19
15:15
Recommendations
Argenx analyst commentary at Piper Jaffray »

Piper Jaffray believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.